NEOIMMUNETECH
NeoImmuneTech, Inc. (NIT) is a clinical-stage T cell-focused biopharmaceutical company, dedicated to expanding the horizon of immuno-oncology and enhancing immunity to infectious diseases. NIT is led by the scientific founder and inventor of NT-I7 (efineptakin alfa) and complemented by a strong executive team with rich industry experience at companies such as Novartis, BMS, GSK, Pfizer, Amgen, Eli Lilly, MedImmune/AstraZeneca and PwC. NIT is expanding rapidly in personnel and operations, as well as partnering with industry and academic leaders to investigate NT-I7 as monotherapy and in combination with various immunotherapeutics.
NEOIMMUNETECH
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.neoimmunetech.com
Total Employee:
1+
Status:
Active
Contact:
+82-31-709-5858
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Font Awesome Apache ReCAPTCHA GoDaddy DNS ReCAPTCHA V2
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-25 | NeoImmuneTech Appoints Jean Fan, M.D., as Chief Clinical Officer |
Official Site Inspections
http://www.neoimmunetech.com Semrush global rank: 7.05 M Semrush visits lastest month: 617
- Host name: ec2-43-200-231-7.ap-northeast-2.compute.amazonaws.com
- IP address: 43.200.231.7
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
